Myelodysplastic Syndromes (MDS)

Bharadhwaj Kolipakkam, MD

Institution

VCU Health

Physician Status

accepting new patients

Primary Disease Area of Focus

Aplastic Anemia

Chronic Lymphocytic Leukemia (CLL)

Chronic Myelomonocytic Leukaemia (CMML)

Myelodysplastic Syndromes (MDS)

Myeloproliferative Neoplasms (MPN)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Read more about Bharadhwaj Kolipakkam, MD

Health Professionals as Patients with Aplastic Anemia, MDS, PNH -2026 May

Read more about Health Professionals as Patients with Aplastic Anemia, MDS, PNH -2026 May

AAMDSIF is pleased to announce that we will host a support group exclusively for Health Care Professionals diagnosed with aplastic anemia aplastic anemia: (ay-PLASS-tik uh-NEE_

MDS Virtual Support Group - Weekday - 2025 March

Read more about MDS Virtual Support Group - Weekday - 2025 March

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with MDS. The group is hosted by AAMDSIF and will be monitored to ensure the privacy and safety of our participants.

Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation

Original Publication Date

November 4, 2024

Article Source

External Web Content

It is being increasingly recognized that many patients with blood cancers harbor germline variants that increase cancer risk.1 For example, 14% of patients with acute myeloid leukemia in the BEAT AML study had germline variants associated with a hereditary hematopoietic…

Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study

Read more about Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists

Read more about Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists

Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone

Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study

Read more about Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study

Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone

Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes

Read more about Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes

Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone

Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions

Read more about Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions

Introduction: Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez)

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes

Read more about Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes

The WHO and International Consensus Classification 2022 classifications of myelodysplastic syndromes myelodysplastic syndromes:

Subscribe to Myelodysplastic Syndromes (MDS)

Your Gift Today Changes Lives

Myelodysplastic Syndromes (MDS)

Bharadhwaj Kolipakkam, MD

Health Professionals as Patients with Aplastic Anemia, MDS, PNH -2026 May

MDS Virtual Support Group - Weekday - 2025 March

Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation

Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study

Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists

Real-world impact of luspatercept on red blood cell transfusions among patients with myelodysplastic syndromes: A United States healthcare claims database study

Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes

Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes

Website Feedback

Patient Helpline